Personalized mRNA Vaccine May Delay Pancreatic Cancer Recurrence
According to a phase I clinical trial published in Nature, a novel personalized RNA neoantigen vaccine combined with immunotherapy and chemotherapy has demonstrated significant potential to delay pancreatic cancer. Background…
Innovative Nanoformulation Combines Ferroptosis and Immunotherapy to Revolutionize Cancer Treatment
Ferroptosis and Immunotherapy in Cancer Treatment Cancer immunotherapy has transformed oncological care by leveraging the immune system’s ability to target tumors. Despite its potential, challenges such as immune evasion and…